Therapeutics(28)
-
A Novel Platform for Rapid Generation of Covalent Biotherapeutics (No. T4-2282)
Covalent drugs have emerged as a groundbreaking modality for improving the affinity, potency, and duration of action of molecularly targeted inhibitors. Prof. ... Read more18694 -
A Method to Treat Lymphedema and Edema of Extremities (No. T4-2270)
An innovative drainage device that addresses the unmet need for effective lymphedema and extremity edema treatments. The device features an implantable inert porous unit connected to a subcutaneous drainage tube leading to an external suction unit. ... Read more19088 -
Adapters for Targeted Viral Vector-Based Therapies (No. T4-2229)
A major challenge in developing viral-based therapies, such as gene therapies, CAR-T cell immunotherapy, and oncolytic virotherapy, is that the most efficient vectors and viruses are not specific, preventing their direct administration to the patient. Prof. ... Read more18691 -
Hyperstable Serum Albumin Variants for Microbial Mass Production (No. T4-2216)
Serum albumins are essential in a wide variety of molecular and cellular applications, including in the medical, biotechnological and cultivated meat industries. ... Read more18682 -
High Throughput Screening Platform For Inhibitors of Viral Membrane Fusion (No. T4-2213)
Enveloped viruses pose significant health risks and lack effective treatments. Inhibiting viral membrane fusion, a crucial step in infection, holds promise for antiviral drug development. Dr. ... Read more18679 -
Natural Human Antibodies to Treat Cancer (No. T4-2152)
Ovarian cancer is the fifth leading cause of cancer-related death in women. Due to a lack of early detection methods, it is often diagnosed at a late stage, resulting in negligible changes to cure. ... Read more17825 -
Novel Combination Therapy For Improved Management of Depression (No. T4-2129)
Psychiatric disorders, especially major depressive disorder (MDD), are leading causes of disability and premature death across the globe, with patients showing a heightened risk of self-harm and suicidal ideation. Prof. ... Read more6097 -
Modulating Weight Gain and Loss (No. T4-2078)
Prof. Elinav and his team have developed a novel approach to prevent weight gain by better understanding smoking cessation-associated weight gain (SCWG). ... Read more17357 -
Treatment for Ewing Sarcoma Using ETS Proteins (No. T4-2068)
Ewing sarcoma (ES) is a common bone malignancy in children and young adolescents which is usually treated by systemic chemotherapy. In about 25% of the cases, cancer has already spread to other parts of the body at the time of diagnosis. ... Read more6154 -
Increasing Immunotherapy Efficacy of Anti PD-L1 (No. T4-2059)
Immunotherapy has revolutionized cancer treatment by activating the immune system to attack tumor cells. However, notable limitations remain, including differential responses between individuals and cancer types. Dr. ... Read more17039